Kamyar Kalantar-Zadeh M.D. to Heart Failure
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Heart Failure.
Connection Strength
4.584
-
Nomenclature in nephrology: preserving 'renal' and 'nephro' in the glossary of kidney health and disease. J Nephrol. 2021 06; 34(3):639-648.
Score: 0.687
-
Volume Balance and Intradialytic Ultrafiltration Rate in the Hemodialysis Patient. Curr Heart Fail Rep. 2017 10; 14(5):421-427.
Score: 0.541
-
Heart Failure Increases the Risk of Adverse Renal Outcomes in Patients With Normal Kidney Function. Circ Heart Fail. 2017 Aug; 10(8).
Score: 0.535
-
Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation. 2012 Feb 07; 125(5):677-84.
Score: 0.364
-
Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation. 2009 Feb 10; 119(5):671-9.
Score: 0.296
-
Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol. 2008 Jun 02; 101(11A):89E-103E.
Score: 0.283
-
Epidemiology of dialysis patients and heart failure patients. Semin Nephrol. 2006 Mar; 26(2):118-33.
Score: 0.242
-
Obesity paradox as a component of reverse epidemiology in heart failure. Arch Intern Med. 2005 Aug 8-22; 165(15):1797; author reply 1797-8.
Score: 0.233
-
Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004 Apr 21; 43(8):1439-44.
Score: 0.213
-
Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome: Results from the BETonMACE Randomized Controlled Trial. Clin J Am Soc Nephrol. 2021 05 08; 16(5):705-716.
Score: 0.173
-
Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study. Cardiovasc Diabetol. 2021 01 07; 20(1):13.
Score: 0.170
-
?-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis. Am J Kidney Dis. 2021 05; 77(5):704-712.
Score: 0.168
-
Comparisons of sleep apnoea rate and outcomes among patients with resistant and non-resistant hypertension. Respirology. 2016 11; 21(8):1486-1492.
Score: 0.124
-
Plasma renin activity and its association with ischemic heart disease, congestive heart failure, and cerebrovascular disease in a large hypertensive cohort. J Clin Hypertens (Greenwich). 2014 Nov; 16(11):805-13.
Score: 0.110
-
Do anthropometric indices accurately reflect directly measured body composition in men and women with chronic heart failure? Congest Heart Fail. 2011 Mar-Apr; 17(2):90-2.
Score: 0.085
-
Comparison of direct body composition assessment methods in patients with chronic heart failure. J Card Fail. 2010 Nov; 16(11):867-72.
Score: 0.082
-
Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc. 2010 Jul; 85(7):609-17.
Score: 0.082
-
Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008 Jul; 156(1):13-22.
Score: 0.071
-
Hypophosphataemia risk associated with ferric carboxymaltose in heart failure: A pooled analysis of clinical trials. ESC Heart Fail. 2023 Apr; 10(2):1294-1304.
Score: 0.049
-
Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension. Kidney Int. 2015 Sep; 88(3):622-32.
Score: 0.029
-
Mechanism and novel therapeutic approaches to wasting in chronic disease. Maturitas. 2013 Jul; 75(3):199-206.
Score: 0.025
-
Erythropoietin in kidney disease and type 2 diabetes. N Engl J Med. 2011 01 27; 364(4):384-5; author reply 385-6.
Score: 0.021